Načítá se...
克唑替尼治疗ALK阳性晚期非小细胞肺癌患者的疗效观察
BACKGROUND AND OBJECTIVE: The aim of this study is to explore clinical efficacy of crizotinib in advanced anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer. METHODS: Twenty-eight patients with advanced non-small cell lung cancer habouring ALK positive were randomly divided into cr...
Uloženo v:
| Vydáno v: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
中国肺癌杂志编辑部
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000091/ https://ncbi.nlm.nih.gov/pubmed/26483333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2015.10.03 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|